Previous close | 68.34 |
Open | 68.75 |
Bid | 70.36 x 900 |
Ask | 75.05 x 900 |
Day's range | 67.33 - 70.43 |
52-week range | 61.05 - 138.47 |
Volume | |
Avg. volume | 557,580 |
Market cap | 2.16B |
Beta (5Y monthly) | 1.34 |
PE ratio (TTM) | 26.87 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.80 (1.17%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
On April 30, 2024, Pat Beyer, Chief Operating Officer of Conmed Corp (NYSE:CNMD), purchased 3,000 shares of the company, as reported in a recent SEC Filing.
CONMED Corporation (NYSE:CNMD) Q1 2024 Earnings Call Transcript April 25, 2024 CONMED Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by and welcome to CONMED’s First Quarter Fiscal Year 2024 Earnings Conference Call. At this […]
CONMED ( NYSE:CNMD ) First Quarter 2024 Results Key Financial Results Revenue: US$312.3m (up 5.7% from 1Q 2023). Net...